Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases

Osteoprotegerin (OPG) is a glycoprotein involved in the regulation of bone remodelling. OPG regulates osteoclast activity by blocking the interaction between the receptor activator of nuclear factor kappa B (RANK) and its ligand (RANKL). More and more studies confirm the relationship between OPG and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutka, Mieczysław, Bobiński, Rafał, Wojakowski, Wojciech, Francuz, Tomasz, Pająk, Celina, Zimmer, Karolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197867/
https://www.ncbi.nlm.nih.gov/pubmed/34313900
http://dx.doi.org/10.1007/s10741-021-10153-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197867/
https://www.ncbi.nlm.nih.gov/pubmed/34313900
http://dx.doi.org/10.1007/s10741-021-10153-2

Ejemplares similares